Clin2
NCT06720883Possibly a fitRecruiting

Robot-assisted surgery for bile duct cancer

Cholangiocarcinoma CancerPerihilar Cholangiocarcinoma

Part of Cancer clinical trials.

This study tests whether robot-assisted surgery is safe and effective for people with perihilar cholangiocarcinoma (a type of bile duct cancer). It may be a good fit for patients whose cancer has not spread and who are healthy enough for major surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
32 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have a confirmed or highly suspected bile duct cancer (called perihilar cholangiocarcinoma).
  • You have had a CT scan of your belly with contrast dye to check the cancer's stage.
  • You understand the study and are willing to follow its rules.
  • You can give written permission (informed consent) to take part.
  • Your doctors plan to treat the cancer with the goal of curing it (curative intent), following official guidelines.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06125769Recruiting
Liver transplant for hard-to-treat bile duct cancer

This trial studies liver transplantation to treat a specific bile duct cancer (perihilar cholangiocarcinoma) that cannot be removed by surgery. It aims to see if a transplant can help when standard chemotherapy has kept the cancer stable.

Padova, PADOVA
NCT06923475Recruiting· Phase 2/Phase 3
Chemo plus immunotherapy before surgery for bile duct cancer

This trial tests whether giving chemotherapy (gemcitabine and cisplatin) combined with immunotherapy (pembrolizumab) before and after surgery can improve outcomes compared to having surgery right away. It is for people with bile duct cancer that can be removed or is borderline removable.

Amsterdam
NCT04993131Recruiting
Liver transplant for non-surgical bile duct cancer

This trial studies liver transplantation for people with a specific type of bile duct cancer near the liver that cannot be safely removed by surgery. It aims to improve outcomes by offering a transplant after the cancer responds to chemotherapy and spread has been ruled out on scans.

Oslo
NCT06037980Recruiting· Phase 2/Phase 3
Chemotherapy before surgery for high-risk bile duct cancer

This trial tests whether receiving chemotherapy (cisplatin, gemcitabine, and nab-paclitaxel) before surgery can improve outcomes for people with high-risk bile duct or gallbladder cancer. It compares this approach to going straight to surgery.

Ancona
NCT06246448Recruiting
Robot vs open surgery for gallbladder cancer

This trial compares robot-assisted surgery to open surgery for people with gallbladder cancer that has been found after a gallbladder removal. The goal is to see which approach is better for the radical removal of remaining cancer.

Stockholm
NCT05755594Not yet recruiting
Robot-assisted surgery for pancreatic tumors

This study looks at how safe and effective robot-assisted surgery is for removing tumors in the pancreas or nearby bile ducts. It aims to help people who are eligible for this type of surgery.

Hear when a new Cholangiocarcinoma Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.